Baldrige Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$334K Sell
2,155
-111
-5% -$17.9K 0.14% 86
2022
Q4
$400K Buy
2,266
+134
+6% +$23.1K 0.18% 75
2022
Q3
$348K Sell
2,132
-59
-3% -$9.98K 0.17% 83
2022
Q2
$389K Sell
2,191
-67
-3% -$11.9K 0.18% 78
2022
Q1
$400K Sell
2,258
-114
-5% -$19.4K 0.16% 83
2021
Q4
$406K Sell
2,372
-56
-2% -$9.17K 0.16% 76
2021
Q3
$392K Sell
2,428
-87
-3% -$14.8K 0.16% 73
2021
Q2
$414K Sell
2,515
-100
-4% -$16.6K 0.18% 72
2021
Q1
$430K Sell
2,615
-103
-4% -$16.7K 0.24% 61
2020
Q4
$428K Buy
2,718
+40
+1% +$5.9K 0.25% 62
2020
Q3
$399K Hold
2,678
0.27% 59
2020
Q2
$377K Buy
2,678
+81
+3% +$11.8K 0.28% 57
2020
Q1
$341K Hold
2,597
0.3% 55
2019
Q4
$379K Sell
2,597
-127
-5% -$17.2K 0.31% 57
2019
Q3
$352K Sell
2,724
-148
-5% -$19.5K 0.31% 54
2019
Q2
$400K Sell
2,872
-72
-2% -$9.97K 0.37% 49
2019
Q1
$412K Buy
+2,944
New +$394K 0.4% 46

Other funds holding JNJ

Baldrige Asset Management's JNJ Position: Q1 2023 in Review

Baldrige Asset Management reduced its Johnson & Johnson (JNJ) stake by 4.9% in Q1 2023, selling an estimated $17.9K and leaving 2,155 shares worth $334K. The position accounts for 0.14% of the portfolio, ranked #86.

Baldrige Asset Management first reported a position in JNJ in Q1 2019 and has held it in 17 quarters since. The position peaked at $430K in Q1 2021. 3,728 funds tracked by Wall St. Rank hold JNJ as of Q1 2023.

  • Baldrige Asset Management held 2,155 shares of Johnson & Johnson worth $334K as of Q1 2023.
  • Baldrige Asset Management sold 111 Johnson & Johnson shares in Q1 2023, an estimated $17.9K.
  • Johnson & Johnson made up 0.14% of Baldrige Asset Management's portfolio in Q1 2023, its #86 holding.
  • Baldrige Asset Management first reported a position in Johnson & Johnson in Q1 2019 and has held it in 17 quarters since.
  • Baldrige Asset Management's Johnson & Johnson position peaked at $430K in Q1 2021.
  • 3,728 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2023.

Based on Baldrige Asset Management's 13F filing for Q1 2023, filed 17 Apr 2023.